We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PCB:NASDAQPCB Bancorp Analysis

Data as of 2026-06-14 - not real-time

$26.59

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

PCB Bancorp is trading in a bullish technical regime with price comfortably above its 20‑day and 50‑day moving averages and a MACD line that sits above its signal, suggesting continued upward momentum. However, the RSI has surged into overbought territory, and daily volume is on a downtrend, which could foreshadow a short‑term pullback as traders take profits near the recent resistance around $26.77. The stock also benefits from a robust operating margin of roughly 50% and a solid earnings beat in Q1 2026, where net income rose to $10.6 million versus $9.1 million in the prior quarter. Coupled with a dividend yield above 3% and a modest payout ratio under 30%, cash flow generation appears sufficient to sustain the dividend.
From a valuation perspective, the market price sits only slightly above the discounted cash‑flow estimate, implying a fair‑valued stance despite a low trailing PE relative to the industry average. The company’s low beta (~0.7) and moderate 30‑day volatility (~23%) temper downside risk, while its regional‑bank focus introduces typical sector and regulatory considerations. Overall, the blend of strong fundamentals, attractive yield, and technical upside supports a cautiously optimistic outlook, with a watchful eye on potential short‑term consolidation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Overbought RSI indicating potential near‑term pullback
  • Decreasing volume suggesting waning buying pressure
  • Proximity to short‑term resistance level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Bullish MACD crossover and price above key moving averages
  • Strong operating margins and earnings momentum
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Fundamentally solid balance sheet with low leverage
  • Consistent earnings growth and dividend stability
  • Reasonable valuation relative to intrinsic fair value

Key Metrics & Analysis

Financial Health

Revenue Growth17.60%
Profit Margin34.76%
P/E Ratio9.5
ROE10.52%
ROA1.23%
P/B Ratio1.1
Op. Cash Flow$44.9M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI70.1
Support$23.26
Resistance$26.77
MA 20$24.83
MA 50$24.38
MA 200$22.51
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$74.41
Target Price$26.00
Upside/Downside-2.22%
GradeFair
TypeBlend
Dividend Yield3.16%

Risk Assessment

Beta0.70
Volatility23.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.